Gencia Corporation
- UEI
- DNSPBR3SME61
- CAGE
- 46A22
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| In this phase i sbir the breast cancer adenocarcinoma cell line, MCF-7 will be treated with escalating doses of… | National Cancer Institute (NIH) | $196,192 | |
| Scientific research services | ACC Aberdeen Proving Ground | $69,925 |
Grant awards
Quick answers
Is Gencia Corporation registered in SAM.gov?
Gencia Corporation's SAM.gov registration expired on February 24, 2022.
What is Gencia Corporation's most recent federal award?
Gencia Corporation's most recent federal contract award is In this phase i sbir the breast cancer adenocarcinoma cell line, MCF-7 will be treated with escalating doses of… (HHSN261201000097C), from National Cancer Institute (NIH), on September 22, 2010.
On GovTribe
See Gencia Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors